First-of-its-kind digital pathology network powered by PathAI’s AISight® platform expands access to latest AI products, unlocks real-world data value, and fuels collaborative research with biopharma ...
BOSTON, April 30, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in AI-powered pathology solutions, today announced it will present research from the outputs of IBD Explore TM and AIM-HI UC TM at ...
Cleveland Clinic has entered a five-year partnership with PathAI to develop new pathology diagnostics. Announced last week, the collaboration will leverage PathAI’s pathology algorithms for use in ...
BOSTON, Mass. and UTRECHT, Netherlands, Dec. 08, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in artificial intelligence and digital pathology solutions, today announced a partnership with ...
BOSTON, Dec. 09, 2025 (GLOBE NEWSWIRE) -- PathAI , a global leader in AI-powered pathology, today announced that the U.S. Food and Drug Administration (FDA) has qualified AIM-MASH AI Assist through ...
BOSTON & CLEVELAND--(BUSINESS WIRE)--PathAI, a global leader in artificial intelligence (AI)-powered technology for pathology, and Cleveland Clinic today announced a five-year strategic collaboration ...
BOSTON, Mass. and ZURICH, Switzerland, Jan. 08, 2026 (GLOBE NEWSWIRE) -- PathAI, a global leader in AI-powered pathology, today announced a strategic collaboration with University Hospital Zurich (USZ ...
Why a Tech Power Player? For being a leader in AI-powered medical diagnostics. Dr. Andrew Beck is a Brown University-trained pathologist who did his residency at Stanford University and then stuck ...
SECAUCUS, N.J. and BOSTON, May 7, 2024 /CSRwire/ - Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, and PathAI, a global provider of artificial intelligence-powered ...
BOSTON--(BUSINESS WIRE)--PathAI, a global leader in artificial intelligence (AI)-powered technology for pathology, today announced that their recent research will be presented at the 2022 AACR annual ...